Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.

MLA

Maza, A., et al. “Oral Cyclosporin in Psoriasis: A Systematic Review on Treatment Modalities, Risk of Kidney Toxicity and Evidence for Use in Non-Plaque Psoriasis.” Journal of the European Academy of Dermatology & Venereology, vol. 25, May 2011, pp. 19–27. EBSCOhost, https://doi.org/10.1111/j.1468-3083.2011.03992.x.

APA

Maza, A., Montaudié, H., Sbidian, E., Gallini, A., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B., Joly, P., Jullien, D., Le Maître, M., Misery, L., Richard, M.-A., Ortonne, J.-P., & Paul, C. (2011). Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. Journal of the European Academy of Dermatology & Venereology, 25, 19–27. https://doi.org/10.1111/j.1468-3083.2011.03992.x

Chicago

Maza, A., H. Montaudié, E. Sbidian, A. Gallini, S. Aractingi, F. Aubin, H. Bachelez, et al. 2011. “Oral Cyclosporin in Psoriasis: A Systematic Review on Treatment Modalities, Risk of Kidney Toxicity and Evidence for Use in Non-Plaque Psoriasis.” Journal of the European Academy of Dermatology & Venereology 25 (May): 19–27. doi:10.1111/j.1468-3083.2011.03992.x.